LDLR and hyperlipidemia: The exact mechanisms responsible for cyclosporine-induced hyperlipidemia remain unclear, but cyclosporine was demonstrated to decrease expression of LDL receptors in hepatocytes therefore inhibiting an uptake of LDL [14,15].